Biblio Discovery — Demo Discovery Service

12 hasil untuk "Ana Lopez"

Menampilkan 1–12 · 0,15 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Factors determining antibiotic use in the general population: A qualitative study in Spain

    Olalla Vazquez-Cancela; Laura Souto-Lopez; Juan M. Vazquez-Lago dkk.

    PLOS ONE, Vol. 16 No. 2 · 2021 · Inggris · PLOS Scopus

    Background: Antibiotic resistance is an important Public Health problem and many studies link it to antibiotic misuse. The population plays a key role in such misuse. Objective: The aim of this study was thus to explore the factors that might influence antibiotic use and resistance in the general…

  2. Artikel Jurnal Teks lengkap

    Fifteen-Year Trends in the Prevalence of Diabetes among Hospitalized HIV-Infected Patients in Spain (1997-2012)

    Alejandro Alvaro-Meca; Rodrigo Jiménez-Garcia; Isabel Jimenez-Trujillo dkk.

    PLOS ONE, Vol. 11 No. 9 · 2016 · Inggris · PLOS Scopus

    Objective: To describe trends in the prevalence of diabetes among hospitalized HIV-infected patients between 1997 and 2012 in Spain and compare them with those of age- and sex-matched non–HIV-infected patients. Methods: The study was based on Spanish national hospital discharge data. We performed a…

  3. Artikel Jurnal Teks lengkap

    National Trends over One Decade in Hospitalization for Acute Myocardial Infarction among Spanish Adults with Type 2 Diabetes: Cumulative Incidence, Outcomes and Use of Percutaneous Coronary Intervention

    Ana Lopez-de-Andres; Rodrigo Jimenez-Garcia; Valentin Hernandez-Barrera dkk.

    PLoS ONE, Vol. 9 No. 1 · 2014 · Inggris · PLOS Scopus

    Background: This study aims to describe trends in the rate of acute myocardial infarction (AMI) and use of percutaneous coronary interventions (PCI) in patients with and without type 2 diabetes in Spain, 2001–2010. Methods: We selected all patients with a discharge of AMI using national hospital…

  4. Artikel Jurnal Teks lengkap

    Prediction of in-hospital mortality after pancreatic resection in pancreatic cancer patients: A boosting approach via a population-based study using health administrative data

    Jose F. Velez-Serrano; Daniel Velez-Serrano; Valentin Hernandez-Barrera dkk.

    PLOS ONE, Vol. 12 No. 6 · 2017 · Inggris · PLOS Scopus

    Background: One reason for the aggressiveness of the pancreatic cancer is that it is diagnosed late, which often limits both the therapeutic options that are available and patient survival. The long-term survival of pancreatic cancer patients is not possible if the tumor is not resected, even among…

  5. Artikel Jurnal Teks lengkap

    Bronchiectasis in patients hospitalized with acute exacerbation of COPD in Spain: Influence on mortality, hospital stay, and hospital costs (2006-2014) according to gender

    Gema Sánchez-Muñoz; Ana Lopez-de-Andrés; Valentín Hernández-Barrera dkk.

    PLOS ONE, Vol. 14 No. 1 · 2019 · Inggris · PLOS Scopus

    Purpose: The objectives of this study were to analyze the characteristics of male and female patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) during 2006–2014 according to the presence or absence of bronchiectasis and to study the factors associated…

  6. Artikel Jurnal Teks lengkap

    RasGRPs Are Targets of the Anti-Cancer Agent Ingenol-3-Angelate

    Xiaohua Song; Ana Lopez-Campistrous; Lucy Sun dkk.

    PLoS ONE, Vol. 8 No. 8 · 2013 · Inggris · PLOS Scopus

    Ingenol-3–angelate (I3A) is a non-tumor promoting phorbol ester-like compound identified in the sap of Euphoria peplus. Similar to tumor promoting phorbol esters, I3A is a diacylglycerol (DAG) analogue that binds with high affinity to the C1 domains of PKCs, recruits PKCs to cellular membranes and…

  7. Artikel Jurnal Teks lengkap

    Nationwide trends in dementia subtypes and in-hospital mortality among hospitalizations with type 2 diabetes in Spain, 2021–2024: A focus on sex disparities

    Natividad Cuadrado-Corrales; Diana María Mérida; Ana Lopez-de-Andres dkk.

    PLOS One, Vol. 21 No. 9 · 2026 · Inggris · PLOS Scopus

    Background: The co-occurrence of type 2 diabetes mellitus (T2DM) and dementia represents a major public health challenge in Spain, where prevalence among hospitalized patients rose from 6.9% in 2011 to 10.6% in 2020. However, post-pandemic trends and sex-specific clinical outcomes remain…

  8. Artikel Jurnal Teks lengkap

    Effective Detection of Human Leukocyte Antigen Risk Alleles in Celiac Disease Using Tag Single Nucleotide Polymorphisms

    Alienke J. Monsuur; Paul I. W. de Bakker; Alexandra Zhernakova dkk.

    PLoS ONE, Vol. 3 No. 5 · 2008 · Inggris · PLOS Scopus

    Background: The HLA genes, located in the MHC region on chromosome 6p21.3, play an important role in many autoimmune disorders, such as celiac disease (CD), type 1 diabetes (T1D), rheumatoid arthritis, multiple sclerosis, psoriasis and others. Known HLA variants that confer risk to CD, for example…

  9. Artikel Jurnal Teks lengkap

    Trends in the Prevalence of Depression in Hospitalized Patients with Type 2 Diabetes in Spain: Analysis of Hospital Discharge Data from 2001 to 2011

    Ana Lopez-de-Andrés; Mª Isabel Jiménez-Trujillo; Valentín Hernández-Barrera dkk.

    PLOS ONE, Vol. 10 No. 2 · 2015 · Inggris · PLOS Scopus

    Background: This study aims to describe trends in the prevalence of depression among hospitalized patients with type 2 diabetes in Spain, 2001–2011. Methods: We selected patients with a discharge diagnosis of type 2 diabetes using national hospital discharge data. Discharges were grouped by…

  10. Artikel Jurnal Teks lengkap

    Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials

    Lucia Lopez-Anglada; Cecilia Cueto-Felgueroso; Laura Rosiñol dkk.

    PLOS ONE, Vol. 13 No. 9 · 2018 · Inggris · PLOS Scopus

    We investigated the prognostic impact and clinical utility of serum free light chains (sFLC) and serum heavy-light chains (sHLC) in patients with multiple myeloma treated according to the GEM2005MENOS65, GEM2005MAS65, and GEM2010MAS65 PETHEMA/GEM phase III clinical trials. Serum samples collected…